Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Methacrylic Acid - Ethyl Acrylate Copolymer

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6BUDESONIDE

    02 1DEXILANT

    03 3DIMETHYL FUMARATE

    04 1ENTOCORT EC

    05 1ESOMEPRAZOLE MAGNESIUM

    06 5FENOFIBRIC ACID

    07 1OMEPRAZOLE MAGNESIUM

    08 1ORTIKOS

    09 1PANCREAZE

    10 1PROCYSBI

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    DR REDDYS LABS SA
    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206623

    Country : US

    Patented : No

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACCORD HLTHCARE

    DIMETHYL FUMARATE

    arrow
    2024 ACI Convention
    Not Confirmed
    ACCORD HLTHCARE
    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210499

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    AMNEAL PHARMS

    BUDESONIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    AMNEAL PHARMS
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206200

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GLENMARK PHARMS LTD

    DIMETHYL FUMARATE

    arrow
    2024 ACI Convention
    Not Confirmed
    GLENMARK PHARMS LTD
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210309

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    RISING

    CHOLINE FENOFIBRATE

    arrow
    2024 ACI Convention
    Not Confirmed
    RISING
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 211626

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    TAKEDA PHARMS USA

    DEXLANSOPRAZOLE

    arrow
    2024 ACI Convention
    Not Confirmed
    TAKEDA PHARMS USA
    Japan
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DEXLANSOPRAZOLE

    Drug : DEXILANT

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 22287

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    VIVUS INC

    PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)

    arrow
    2024 ACI Convention
    Not Confirmed
    VIVUS INC
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)

    Drug : PANCREAZE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 22523

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ZYDUS PHARMS

    BUDESONIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    ZYDUS PHARMS
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206134

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    ENDO OPERATIONS

    CHOLINE FENOFIBRATE

    arrow
    2024 ACI Convention
    Not Confirmed
    ENDO OPERATIONS
    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 201573

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NORVIUM BIOSCIENCE

    CHOLINE FENOFIBRATE

    arrow
    2024 ACI Convention
    Not Confirmed
    NORVIUM BIOSCIENCE
    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 200913

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF